A “Tail” of Immunotherapy in Metastatic Prostate Cancer

Russell K. Pachynski

doi:10.1016/j.eururo.2020.08.040

A “Tail” of Immunotherapy in Metastatic Prostate Cancer

Russell K. Pachynski

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	831-833
Number of pages	3
Journal	European Urology
Volume	78
Issue number	6
DOIs	https://doi.org/10.1016/j.eururo.2020.08.040
State	Published - Dec 2020

Access to Document

10.1016/j.eururo.2020.08.040

Cite this

@article{aaf0a574f937478ca6f14b58ee486854,

title = "A “Tail” of Immunotherapy in Metastatic Prostate Cancer",

author = "Pachynski, \{Russell K.\}",

note = "Funding Information: Conflicts of interest: The author has received personal fees and nonfinancial support from BMS and Genentech/Roche, personal fees from Dendreon, EMD Serono/Pfizer, Genomic Health, AstraZeneca, Sanofi, Merck, Jounce Therapeutics, and Bayer, and grants from Janssen. He is an investigator on the BMS Checkmate 650 trial (NCT02985957) and serves on the steering committee. Funding Information: Acknowledgments: The author is supported in part by the American Cancer Society, the Prostate Cancer Foundation, and The Kimmel Foundation.",

year = "2020",

month = dec,

doi = "10.1016/j.eururo.2020.08.040",

language = "English",

volume = "78",

pages = "831--833",

journal = "European Urology",

issn = "0302-2838",

number = "6",

}

TY - JOUR

T1 - A “Tail” of Immunotherapy in Metastatic Prostate Cancer

AU - Pachynski, Russell K.

N1 - Funding Information: Conflicts of interest: The author has received personal fees and nonfinancial support from BMS and Genentech/Roche, personal fees from Dendreon, EMD Serono/Pfizer, Genomic Health, AstraZeneca, Sanofi, Merck, Jounce Therapeutics, and Bayer, and grants from Janssen. He is an investigator on the BMS Checkmate 650 trial (NCT02985957) and serves on the steering committee. Funding Information: Acknowledgments: The author is supported in part by the American Cancer Society, the Prostate Cancer Foundation, and The Kimmel Foundation.

PY - 2020/12

Y1 - 2020/12

UR - https://www.scopus.com/pages/publications/85090712996

U2 - 10.1016/j.eururo.2020.08.040

DO - 10.1016/j.eururo.2020.08.040

M3 - Editorial

C2 - 32933793

AN - SCOPUS:85090712996

SN - 0302-2838

VL - 78

SP - 831

EP - 833

JO - European Urology

JF - European Urology

IS - 6

ER -

A “Tail” of Immunotherapy in Metastatic Prostate Cancer

Access to Document

Other files and links

Cite this